AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 217 filers reported holding AMICUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,511,832 | -86.9% | 946,697 | -86.5% | 0.03% | -87.0% |
| Q2 2023 | $87,931,304 | +252.5% | 7,000,900 | +211.3% | 0.26% | +239.0% |
| Q1 2023 | $24,942,830 | +45.1% | 2,249,128 | +36.6% | 0.08% | +11.6% |
| Q3 2022 | $17,188,000 | +43.2% | 1,646,400 | +47.3% | 0.07% | +35.3% |
| Q2 2022 | $12,006,000 | +166.6% | 1,117,900 | +135.1% | 0.05% | +183.3% |
| Q1 2022 | $4,503,000 | -87.9% | 475,500 | -87.7% | 0.02% | -89.3% |
| Q2 2021 | $37,282,000 | +2028.0% | 3,867,400 | +2081.0% | 0.17% | +2000.0% |
| Q1 2021 | $1,752,000 | -91.9% | 177,322 | -88.5% | 0.01% | -92.8% |
| Q3 2020 | $21,760,000 | +41.7% | 1,541,042 | +51.3% | 0.11% | +11.0% |
| Q2 2020 | $15,359,000 | -25.9% | 1,018,529 | -54.6% | 0.10% | -40.5% |
| Q1 2020 | $20,724,000 | +104.0% | 2,242,900 | +77.0% | 0.17% | +171.0% |
| Q3 2019 | $10,161,000 | -73.1% | 1,267,000 | -58.1% | 0.06% | -68.7% |
| Q2 2019 | $37,760,000 | +3.7% | 3,025,664 | -20.4% | 0.20% | +11.2% |
| Q4 2018 | $36,410,000 | +29.3% | 3,800,585 | +63.2% | 0.18% | +53.4% |
| Q3 2018 | $28,160,000 | +154.9% | 2,329,200 | +229.3% | 0.12% | +163.6% |
| Q2 2018 | $11,048,000 | -75.8% | 707,300 | -77.7% | 0.04% | -77.7% |
| Q4 2017 | $45,618,000 | +73.9% | 3,170,100 | +82.2% | 0.20% | +68.4% |
| Q3 2017 | $26,231,000 | -10.9% | 1,739,446 | -40.5% | 0.12% | -29.1% |
| Q2 2017 | $29,436,000 | +37.6% | 2,923,100 | -2.6% | 0.16% | +38.7% |
| Q1 2017 | $21,394,000 | +64.9% | 3,000,500 | +227.3% | 0.12% | +32.2% |
| Q2 2015 | $12,971,000 | +585.6% | 916,700 | +427.1% | 0.09% | +592.3% |
| Q1 2015 | $1,892,000 | +62.3% | 173,900 | -11.2% | 0.01% | +44.4% |
| Q3 2014 | $1,166,000 | – | 195,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |